IBM Beats Expectations on Q2 Earnings, Stock Falls

Despite beating on revenue, EPS, and cash flow, IBM shares declined $267.46 −14.55 (−5.16%) in after-hours trading. Investors appear cautious over the mixed performance in Consulting and muted short-term upside signals.


Key Financial Results (Quarter Ended June 30, 2025)

MetricActualYoY Change
Revenue$17.0B▲8%
Operating EPS (Non-GAAP)$2.80▲15%
GAAP EPS$2.31▲18%
Adjusted EBITDA$4.7B▲16%
Free Cash Flow (Q2)$2.8B▲$200M
Operating Gross Margin60.1%▲230 bps
Operating Pre-Tax Margin18.8%▲110 bps

Segment Breakdown

Software: $7.39B (▲10%)

  • Red Hat: ▲14% CC; OpenShift ARR: $1.7B
  • Automation: ▲14% CC
  • Data: ▲7% CC
  • Transaction Processing: ▼2% CC

Infrastructure: $4.14B (▲14%)

  • IBM Z: ▲67% CC on z17 launch
  • Hybrid Infra: ▲19% CC
  • Distributed Infra: ▼17% CC

Consulting: $5.31B (▲3%)

  • Flat at constant currency
  • GenAI business >$1B this quarter
  • Client caution continues; backlogs up 4% YoY

Strategic Highlights

  • GenAI book of business exceeds $7.5B
  • Over 150 AI agents launched in watsonx Orchestrate
  • z17 mainframe and Telum II chip enable real-time AI inferencing (450B ops/day)
  • Expanded AI/cloud partnerships with Oracle, AWS, Salesforce, Microsoft, EY
  • Power11 announced in July for high-resilience hybrid workloads
  • DataStax acquisition closed; enhances real-time AI applications

FY25 Outlook

MetricGuidance
Revenue Growth (CC)≥5%
Free Cash FlowRaised to >$13.5B
Operating Pre-Tax MarginRaised by +1 pt YoY
Software GrowthApproaching double digits
Red Hat GrowthMid-teens expected
ConsultingRemains cautious

Takeaway

IBM delivered strong execution in Software and Infrastructure, but Consulting headwinds and investor sensitivity to growth quality weighed on the stock. AI growth remains robust, but the path to monetization and near-term acceleration may not yet fully convince markets.